drugset / Trial / NCT02605538
Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively
Non-randomizedParallel-groupOpen-labelPrevention
Summary
CF patients are at risk for hepatic disease. Vaccination is recommended to all CF patients according to European consensus. The aim of the study is to vaccinate as many patients as possible and to follow up whether immunization has been complete.
Timeline
- Start
- 2015-09-01
- Primary completion
- 2023-12
- Completion
- 2025-12-31
Outcome
Outcome not reported
Stopped: “Time and resource deficiency at the Stockholm CF Center.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vaccine against hepatitis A and B | Vaccine | — | — |